Easy Peasy #50: Build Your Dividend Portfolio & Live Off Dividends with Pre-Selected Stock Sets

Dividend Growing Stock Sets – Start with $300, $500, or $1,000 Weekly

MaxDividends Mission: Helping & Supporting Everyone in Building a Growing Passive Income, Retiring Early, and Living Off Dividends.

In this section, we share ready-made sets of promising dividend growth stocks with strong future dividend potential.

We also track performance and provide portfolio links for each set, so you can monitor past results and real-time updates.

⭐️ Premium content for paid subscribers

---

Intro

Another tariff twist and earnings boost send stocks flying

The Dow jumped +507.85 points (+1.14%) to 45,010, the S&P 500 added +49.34 (+0.78%) to hit 6,358, and the Nasdaq rose +127.33 (+0.61%) to close at 21,020, while the Russell 2000 surged +34.38 (+1.53%) to finish at 2,283 — its highest level in 5 months. Stocks ripped higher after news broke of a finalized US–Japan trade deal slashing auto tariffs to 15% (from a 25% threat) and Japan pledging $550B in US investment.

That lit up global autos and gave US stocks a boost right at the open. Midday, a Financial Times report added fuel, saying the US and EU were close to a 15% mutual tariff agreement, covering planes, spirits, and medical devices — helping avoid a hike to 30% threatened for August.

Earnings also helped: utilities, power, and consumer meme stocks saw wild swings. Small caps led again, and with the S&P notching its 12th record close this year, the bull keeps charging despite valuation warnings and a sleepy VIX.

📊 Economic Data

• June Existing Home Sales3.93M vs. 4.00M est – fell -2.7% MoM, lowest since May 2024; median home price $435,300, new record high

• Inventory1.53M units, 4.7 months supply; first-time buyers = 30%, investors = 14%, all-cash = 29%, distressed sales = 3%

🔩 Autos

• TM jumped after Japan–US deal slashed tariffs on car exports to 15%, with Japan shipping 1.4M vehicles to the US in 2024

• NSANY surged on same trade catalyst; automakers welcome relief from higher import taxes

• HMC rose as tariffs ease and Japan commits billions in US investment across auto and tech sectors

🛒 Retail, Consumer Staples & Restaurants

• GPRO spiked on meme momentum, no news — short squeeze vibes

• LVLU joined meme rally, rebounding from lows on high volume

• BYND surged as retail traders piled into underperformers

• DNUT up with meme peers — classic short-interest target

• RKT caught in meme crossfire — big jump with no catalyst

• HAS raised FY outlook; sees mid-single-digit rev growth, adj EBITDA $1.17B–$1.20B vs. prior $1.1B–$1.15B

🎰 Leisure, Gaming & Lodging

• HLT Q2 EPS $2.20 (vs. est. $2.04), adj EBITDA $1.01B (vs. $962.9M) but FY guide trimmed

• VIK target hiked to $70 from $51 by BofA — premium cruise growth intact

• CCL target raised to $38 from $31, demand strong across EU sailings

• RCL held at Neutral by BofA — less upside than VIK/CCL peers

⚡ Energy, Industrials & Materials

• MTDR beat on Q2 and nudged FY guide higher, midstream unit strong

• BKR beat EBITDA, raised FY guide, strong margins

• WFRD rose on earnings beat, helping OIH bounce

• EQT, CNX, AR fell as natgas dipped another 5.38%

• VLO down on Reuters report of sale talks for Benicia refinery

🏦 Banks & 💳 FinTech

• NTRS beat Q2 EPS, CEO says no plans to sell — stock held steady

• FI cut FY rev growth view to ~10% (from 10–12%) on soft Clover volume

• MCO beat EPS $3.56 (vs. est. $3.39), raised FY guide to $13.50–$14

• CHUBB EPS $6.14 beat; stronger underlying combined ratio (82%), higher catastrophe losses

• CSGP topped Q2 rev/EBITDA, raised FY guide, Q3 EBITDA guide slightly under Street

🏥 Healthcare

• BSX Q2 organic growth +17.4%, EPS $0.75, raised FY guide

• ISRG beat on EPS $1.81 (vs. $1.55), strong US dV5 placements

• TMO rev $10.85B (vs. est. $10.7B), raised FY EPS to $22.22–$22.84

🧪 Biotech & Life Sciences

• ABVX exploded +500% after strong Phase III UC trial for obefazimod

• ARWR warned SRPT may miss $100M–$200M milestone payments

• DTIL got FDA orphan tag for Duchenne drug PBGENE-DMD

🚂 Transports

• CNI missed Q2 revs C$4.27B (vs. C$4.34B est), cut 2025 EPS guide, pulled long-term outlook — double downgrade

• OTIS Q2 rev miss $3.6B vs. est. $3.706B, guided lower

• LII beat Q2 EPS $7.82, raised FY EPS to $23.25–$24.25

• PCAR upgraded at UBS to Neutral, tgt to $100

🚁 Aerospace & Defense

GD beat Q2 EPS/revs on strength in marine and biz jets; aerospace rev +4.1% YoY, marine systems +22.2%

📰 Internet, Media & Telecom

• AT beat top/bottom line, postpaid subs strong

• CHTR, CMCSA signed exclusive deal with TMUS for mobile network sharing

• RBLX downgraded to Outperform (from Strong Buy) at Raymond James, tgt to $130 from $81

🔌 Semiconductors, Hardware & Software

• TXN slid despite strong Q2; Q3 guide soft, EPS weak, cited pull-ins from tariffs and shallow auto recovery

• NXPI beat Q2 and guided up on cyclical auto/industrial strength

• ON, ADI, STM dropped in sympathy with TXN

• AMD CEO said Arizona TSM chips cost +5–20% more, per Bloomberg

🧠 What’s Next?

• Big night for tech — earnings from GOOGL, TSLA, IBM after the bell.

• With only 124 S&P companies reporting so far, beat rate is sky-high: EPS beats = 85% (vs. avg. 66%), revenue beats = 77% (vs. avg. 63%).

• Average stock gain on earnings day? +0.72%.

• Momentum’s hot, sentiment strong — now it’s up to Big Tech to keep it rolling.

--

But none of this news really matters to MaxDividends members. We're focused on growing the cash flow that lands in your pocket every month—not stressing over price swings or stock market noise.

At MaxDividends, we focus on a dividend growth strategy, perfect for investors seeking capital appreciation, solid safety, and a steadily growing income.

A rising dividend is a strong sign that a company is thriving—and wants its shareholders to thrive with it.

---

This week, we’ve rolled out a fresh batch of ready-to-go Stock Sets 💪.

Easy Peasy #50: Pre-Selected Dividend Growth Stock Sets